Fortress Biotech Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

Stock Information for QXO Inc Com Par Value $0.00001 (New)

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About QXO Inc Com Par Value $0.00001 (New)

Journey Medical Corporation Announces Emrosi(TM) Data Analysis to be Presented at the Society of Dermatology Physician Associates (SDPA) 2025 Annual Summer Dermatology Conference
Journey Medical Corporation Announces Emrosi(TM) Featured on "The Balancing Act" Airing on Lifetime TV
Fortress Biotech Announces Closing of Sale of Subsidiary Checkpoint Therapeutics
Journey Medical Corporation Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
Checkpoint Therapeutics Reports First Quarter Financial Results and Recent Corporate Updates
Journey Medical Corporation to Announce First Quarter 2025 Financial Results on May 14, 2025
Fortress Biotech to Participate in the H.C. Wainwright 1st Annual Royalty Company Virtual Conference
Journey Medical Corporation Appoints Ramsey Alloush as Chief Operating Officer

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.